High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma (original) (raw)
References
Ahn HJ, Kwon WK, Choi Y, Cho NH (1998) Expression of cyclin E and cyclin dependent kinase inhibitor, p27KIP in uterin endometrial carcinoma relationship with p53 status. Int J Surg Pathol 6:205–212 ArticleCAS Google Scholar
Akaboshi M, Watanabe J, Fujisawa T, Hattori M, Ohno E, Kuramoto H (2001) Immunohistochemical expression of cdk2 and Ki-67 in human endometrial carcinoma (in Japanese). J Jpn Soc Clin Cytol 40:121–127 Google Scholar
Anayama T, Furihata M, Ishikawa T, OhtsukiY, Ogoshi S (1998) Positive correlation between p27KIP1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 79:439–443 ArticlePubMedCAS Google Scholar
Bamberger AM, Riethdorf L, Milde-Langosch K, Bamberger CM, Thuneke I, Erdmann I, Schulte HM, Loning T (1999) Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia. Virchows Arch 434:423–428 ArticlePubMedCAS Google Scholar
Ben-Izhak O, Lahav-Baratz S, Meretyk S, Ben-Eliezer S, Sabo E, Dirnfeld M, Cohen S, Ciechanover A (2003) Inverse relationship between skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer. J Urol 170:241–245 ArticlePubMedCAS Google Scholar
Bornstein G, Blooms J, Shevah DS, Nakayama K, Pagano M, Hershco A (2003) Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 278:25752–25757 ArticlePubMedCAS Google Scholar
Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193–199 ArticlePubMedCAS Google Scholar
Cheng JD, Werness BA, Babb JS, Meropol NJ (1999) Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Clin Cancer Res 5:1057–1062 PubMedCAS Google Scholar
Fujisawa T, Watanabe J, Akaboshi M, Ohono E, Kuramoto H (2001) Immunohistochemical study on VEGF expression in endometrial carcinoma—comparison with p53 expression, angiogenesis, and tumor histologic grade. J Cancer Res Clin Oncol 127:668–674 PubMedCAS Google Scholar
Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A (2001) The cell-cycle regulatory protein Cks1 is required for SCFSkp2 -mediated ubiqutinylation of p27. Nat Cell Biol 3:321–324 ArticlePubMedCAS Google Scholar
Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slongerland J, Krek W (2001) Skp2 is oncogenic and overexpressed in human cancers. PNAS 98:5043–5048 ArticlePubMedCAS Google Scholar
Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, Hershco A (2001) Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit skp2 in colorectal carcinoma. Cancer 91:1745–1751 ArticlePubMedCAS Google Scholar
Kato N, Watanabe J, Jobo T, Nishimura Y, Fujisawa T, Katmata Y, Kuramoto H (2003) Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological parameters. J Cancer Res Clin Oncol 129:222–226 PubMedCAS Google Scholar
Kimura H, Watanabe J, Hata H, Fujisawa T, Kamata Y, Nishimura Y, Jobo T, Kuramoto H (2004) PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. J Cancer Res Clin Oncol 130:161–168 ArticlePubMedCAS Google Scholar
Kudo Y, Kitajima S, Miyauchi M, Ogawa I, Takata T (2001) High expression of S-phase Kinase-interacting Protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinoma. Cancer Res 61:7044–7047 PubMedCAS Google Scholar
Kyushima N, Watanabe J, IIata II, Jobo T, Kameya T, Kuramoto H (2002) Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J Cancer Res Clin Oncol 128:307–312 ArticlePubMedCAS Google Scholar
Lahav-Baratz S, Ben-Izhak O, Sabo E, Ben-Eliezer S, Lavie O, Ishai D, Ciechanover A, Dirnfeld M (2004) Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium. Mol Hum Reprod 10:567–572 ArticlePubMedCAS Google Scholar
Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3:231–234 ArticlePubMedCAS Google Scholar
Marti A, Wirbelauer C, Scheffnert M, Krek W (1999) Interaction between ubiquitination-protein ligase SCFskp2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1:14–19 ArticlePubMedCAS Google Scholar
Nakayama K, Nagashima H, Minamishima YA, Matsumoto M (2000) Target disruption of skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J 19:2069–2081 ArticlePubMedCAS Google Scholar
Nakayama K, Hatakeyama H, Nakayama K (2001) Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Com 282:853–860 ArticlePubMedCAS Google Scholar
Nishimura Y, Watanabe J, Jobo T, Kato N, Fujisawa T, Kamata Y, Kuramoto H (2004) Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but no with prognosis. Anticancer Res 24:2185–2192 PubMedCAS Google Scholar
Schwartz AL, Ciechanover A (1999) The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50:57–74 ArticlePubMedCAS Google Scholar
Shigemasa K, Gu L, O’Brien TJ, Ohama K (2003) Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 9:1756–1763 PubMedCAS Google Scholar
Signoretti S, Marcotullio LD, Richardson A, Ramaswamy S, Isaac B, Rue M, Monti F, Loda M, Pagano M (2002) Oncogenic role of the ubiquitin ligase subunit skp2 in human breast cancer. J Clin Invest 110:633–641 ArticlePubMedCAS Google Scholar
Singh SP, Lipman J, Goldman H, Ellis Jr FH, Aizenman L, Cangi MG, Signpretti S, Chiau DS, Pagano M, Loda M (1998) Loss or altered subcelluar localization of p27 in Barrett’s associated adenocarcinoma. Cancer Res 58:1730–1735 PubMedCAS Google Scholar
Watanabe J, Sato H, Kanai T, Kamata Y, Jobo T, Hata H, Fujisawa T, Ohno E, Kuramoto H (2002) Paradoxical Expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus—correlation with proliferation and clinicopathological parameters. Br J Cancer 87:81–85 ArticlePubMedCAS Google Scholar
Yang G, Ayala G, Marzo AD, Tian W, Frolov A, Thompson TC, Harper JW (2002) Elevated skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res 8:3419–3426 PubMedCAS Google Scholar
Yanping G, Geoffrey NS, Andrew B, Natasha K (1997) Loss of cyclin-dependent kinase inhibitor p27Kip1 protein in human prostate cancer correlates with tumor grade. Clin Cancer Res 3:2269–2274 PubMed Google Scholar
Zhang H, Kobayashi R, Galaktinov K, Beach D (1995) p19skp1 and p45skp2 are essential elements of the cyclin A-Cdk2 S phase kinase. Cell 82:915–925 ArticlePubMedCAS Google Scholar